Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: Significant roles of total body irradiation and chronic graft-versus-host disease

Bone Marrow Transplantation

Volumn 36, Issue 10, 2005, Pages 867-872

  Yanada, M ^a   Naoe, T ^a   Iida, H ^b   Sakamaki, H ^c   Sakura, T ^d   Kanamori, H ^e   Kodera, Y ^f   Okamoto, S ^g   Kanda, Y ^h   Sao, H ^b   Asai, O ⁱ   Nakai, K ^j   Maruta, A ^k   Kishi, K ^l   Furukawa, T ^m   Atsuta, Y ^a   Yamamoto, K ^a   Tanaka, J ⁿ   Takahashi, S ^o  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Meitetsu Hospital   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^e YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^f JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOKYO HOSPITAL   (Japan)

ⁱ JIKEI UNIVERSITY HOSPITAL   (Japan)

^j KANSAI MEDICAL UNIVERSITY   (Japan)

^k KANAGAWA CANCER CENTER   (Japan)

^l TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

ⁿ HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^o UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Acute lymphoblastic leukemia; Allogeneic; Graft versus host disease; Philadelphia; Stem cell transplantation; Total body irradiation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; METHOTREXATE; TACROLIMUS;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DONOR; FEMALE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SIBLING; SURVIVAL RATE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 27844476033     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705148     Document Type: Article

References (34)

1. Larson RA, Dodge RK, Burns CP et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8811. Blood 1995; 85: 2025-2037.
2. Secker-Walker LM, Prentice HG, Durrant J et al. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol 1997; 96: 601-610.
3. Wetzler M, Dodge RK, Mrozek K et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: The cancer and leukemia Group B experience. Blood 1999; 93: 3983-3993.
4. Thomas X, Danaila C, Le QH et al. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: A single institution experience of 378 consecutive patients over a 21-year period. Leukemia 2001; 15: 1811-1822.
5. Gleissner B, Gokbuget N, Bartram CR et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: A prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood 2002; 99: 1536-1543.
6. Takeuchi J, Kyo T, Naito K et al. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: The JALSG-ALL93 study. Leukemia 2002; 16: 1259-1266.
7. Annino L, Vegna ML, Camera A et al. Treatment of adult acute lymphoblastic leukemia (ALL): Long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863-871.
8. Thomas DA, Faderl S, Cortes J et al. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 2004; 103: 4396-4407.
9. Towatari M, Yanada M, Usui N et al. Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. Blood 2004; 104: 3507-3512.
10. Forman SJ, O'Donnell MR, Nademanee AP et al. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1987; 70: 587-588.
11. Barrett AJ, Horowitz MM, Ash RC et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1992; 79: 3067-3070.
12. Stockschlader M, Hegewisch-Becker S, Kruger W et al. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1995; 16: 663-667.
13. Dunlop LC, Powles R, Singhal S et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1996; 17: 365-369.
14. Sierra J, Radich J, Hansen JA et al. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1997; 90: 1410-1414.
15. Marks DI, Bird JM, Cornish JM et al. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 931-936.
16. Snyder DS, Nademanee AP, O'Donnell MR et al. Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Leukemia 1999; 13: 2053-2058.
17. Cornelissen JJ, Carston M, Kollman C et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: Strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001; 97: 1572-1577.
18. Dombret H, Gabert J, Boiron JM et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia - results of the prospective multicenter LALA-94 trial. Blood 2002; 100: 2357-2366.
19. Esperou H, Boiron JM, Cayuela JM et al. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from the French Bone Marrow Transplantation Society. Bone Marrow Transplant 2003; 31: 909-918.
20. Lee S, Kim DW, Cho B et al. Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: The potential of real-time quantitative reverse-transcription polymerase chain reaction. Br J Haematol 2003; 120: 145-153.
21. Stirewalt DL, Guthrie KA, Beppu L et al. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation. Biol Blood Marrow Transplant 2003; 9: 206-212.
22. Iida H, Sao H, Kitaori K et al. Twenty years' experience in allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group. Int J Hematol 2004; 79: 79-84.
23. Morishima Y, Sasazuki T, Inoko H et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002; 99: 4200-4206.
24. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
25. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
26. Sebban C, Lepage E, Vernant JP et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: A comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. J Clin Oncol 1994; 12: 2580-2587.
27. Attal M, Blaise D, Marit G et al. Consolidation treatment of adult acute lymphoblastic leukemia: A prospective, randomized trial comparing allogeneic vs autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. Blood 1995; 86: 1619-1628.
28. Thomas X, Boiron JM, Huguet F et al. Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075-4086.
29. Hunault M, Harousseau JL, Delain M et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: A GOELAMS trial. Blood 2004; 104: 3028-3037.
30. Yanada M, Emi N, Naoe T et al. Allogeneic myeloablative transplantation for patients aged 50 years and over. Bone Marrow Transplant 2004; 34: 29-35.
31. Passweg JR, Tiberghien P, Cahn JY et al. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant 1998; 21: 153-158.
32. Arnold R, Massenkeil G, Bornhauser M et al. Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia 2002; 16: 2423-2428.
33. Martino R, Giralt S, Caballero MD et al. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: A feasibility study. Haematologica 2003; 88: 555-560.
34. Kanda Y, Izutsu K, Hirai H et al. Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate. Leukemia 2004; 18: 1013-1019.